Auren Rx Review: The Price Is $199, Not $169

Auren Rx does something almost nobody in this market does: it prints two prices for every single item it sells — a discounted subscription rate and an explicit month-to-month rate labelled "no commitment" — and it does it on all ten products, not just the ones where the comparison flatters it. That is the most complete price surface of the seven telehealth sellers we screened in August 2026.

It is also a page that will hand you the wrong number three separate ways if you read it quickly, which is why this review leads with the reading instructions rather than the ladder.

Three ways to misread this page

The first is the molecule selector. Auren Rx's weight-loss page loads with tirzepatide selected, not semaglutide. Glance at it, note "the price", and you have recorded the tirzepatide figure under the semaglutide heading — a $100 error, in the direction that makes the provider look expensive rather than cheap.

The second is the site's own structured data. Every product emits machine-readable pricing to search engines and AI crawlers, and what it emits is the subscribe rung, not the month-to-month one. Anything scraping Auren Rx's pages will file $169 semaglutide and $259 tirzepatide. Those are real, purchasable rates — but they are the committed ones, and if you arrive expecting $169 because an aggregator quoted it at you, the no-commitment price is $30 to $40 higher.

The third is the navigation, which reads "Semaglutide & Tirzepatide from $129/mo". That $129 is the subscribe rate on the microdose program, not the standard one. The cheapest standard GLP-1 rung on the site is $169 subscribed, $199 monthly. "From $129" under a GLP-1 heading understates standard treatment by $70 a month.

None of the three is a fabricated price. All three are real numbers in the wrong slot, which is a more durable problem than a lie — it survives everybody's fact-check. We file the month-to-month figure throughout, which is the rule set out in our methodology and the reason our board and a price-scraper will disagree about this provider.

The GLP-1 ladder, corrected

Standard semaglutide is $199 a month with no commitment, or $169 subscribed. Standard tirzepatide is $299 with no commitment, or $259 subscribed. The microdose program prices semaglutide at $149 monthly or $129 subscribed, and tirzepatide at $250 monthly or $229 subscribed.¹

Two structural things are right here. There is no prepay tier at all, so there is no prepay total masquerading as a monthly rate. And there is no hidden minimum term — the terms say month-to-month, cancellable at any time, and every product page carries an explicit no-commitment rung rather than burying it. Billing runs approximately every 28 to 30 days, which is slightly short of a calendar month and is disclosed as such.

$199 semaglutide and $299 tirzepatide put Auren Rx in the honest middle of what a month of compounded GLP-1 costs, with a genuinely cheap microdose entry. It is a fair competitor on our tirzepatide ruling precisely because the tirzepatide number is a monthly number you can actually buy for one month — which is not true of every provider in this batch.

The rest of the catalogue

NAD+ is where the granularity is: an injection at $209 a month; nasal spray at $169 or $219 for 15 or 30 millilitres at the lower strength, $189 or $249 at the higher one; and a 10% cream at $155 or $215 by size. Sermorelin is $199. Glutathione is $119 as an injection, $109 nasal. GHK-Cu cream is $109, tretinoin $49, oral minoxidil $49. Valacyclovir is $39 or $49 by strength, and estradiol runs $89 or $99 as a patch and $69 or $79 as a tablet.¹ Every one of those is the no-commitment rate; subscribing takes $10 to $40 off depending on the product.

Two of those products — valacyclovir and estradiol — are not in the site's sitemap at all. They exist, they have pages, and a crawler working from the sitemap alone would conclude Auren Rx sells eight things rather than ten. That is a housekeeping fault rather than an integrity one, but it is worth knowing that the published map of this business is incomplete.

There is no research-chemical line, no retatrutide, no testosterone. The catalogue is prescription products and nothing else, which is a cleaner position than most of this cohort holds.

What it will not tell you

Auren Rx never publishes the states it serves. Its terms refer to "certain states" and to "a State Where We Operate", and no list appears anywhere on the site. Every other provider in this batch either publishes a list or claims all 50; this one does neither, and it is the single biggest gap in an otherwise strong disclosure record. Confirming your state before you get attached to a brand is step six of our provider checklist, and here you cannot do it without asking.

The pharmacy is never named individually — you get "the Auren RX Pharmacy Network" — though you may elect a local pharmacy of your own, in which case the membership fee excludes the medication cost. The medical group is Beluga Health, P.A., a real and established telehealth professional association, but no individual prescriber is named and no NPI is published, so nobody here can be checked against the national registry the way The Edit's medical director can. The legal entity is Hades Capital LLC, doing business as Auren RX, with no address published.

The membership fee is charged the day membership commences and is non-refundable once paid. The timing matters and it is in Auren Rx's favour: membership begins after a provider communicates a care plan and you elect to proceed, so it follows clinical review rather than preceding it. That is the opposite of the pattern we found at several providers in this batch, where the card is charged at intake. Cancellation is by email or in-account, and the membership can be paused with no further charges until you order a refill.

Its product pages display star ratings with no review count and no source attached. We are not repeating them and no board should.

We screened the trading name, the legal entity, the medical group and the platform against the FDA's live warning-letter index and found no company-column match.² The pass carried a control — an unrelated telehealth seller with a real February 2026 letter — which returned correctly, so the zero is evidence rather than an empty query.

The ruling

If you can confirm Auren Rx operates in your state, this is one of the two best-documented buys of the seven providers we screened, and the microdose program at $149 a month with no commitment is the most interesting low-dose entry any of them offers. Read the page carefully: switch the selector to the molecule you actually want, and take the number labelled no commitment rather than the one the site broadcasts to machines. Then put it beside Trellis Vitality at $150 semaglutide and Pepti at $99, and start from the full board of verdicts.